Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from SCRIP

15:43 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "SCRIP" found in our extensive news archives from over 250 global news sources.

More Information about SCRIP on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SCRIP for you to read. Along with our medical data and news we also list SCRIP Clinical Trials, which are updated daily. BioPortfolio also has a large database of SCRIP Companies for you to search.

Showing News Articles 1–25 of 3,100+ from SCRIP

Friday 20th July 2018

J&J Maintains Consumer Business Outlook Despite 'Disappointing' Quarter

Tibsovo Approval Makes Agios’ Second AML Approval In A Year; Priced At $26k For 30 Days

Tibsovo is the second targeted therapy approved for a mutation-specific subset of relapsed/refractory AML patients. Agios discovered and jointly markets...    

As Recalls Multiply, EU Agency Studies How To Rid Chinese Firm’s Valsartan API Of Probable Carcinogen

European authorities are examining how a manufacturing process change six years ago may have introduced a probable carcinogen into Zhejiang...    

Deal Watch: Gilead Continues To Add To IO Armamentarium In Collaboration With Gadeta

Deal through Kite Pharma subsidiary focuses on developing gamma delta T-cell receptor therapies. Sanofi inks SHP2 cancer collaboration with Revolution...  

Strong Sobi With New Asset: A Takeover Target For Sanofi?

Swedish rare diseases specialist Sobi has reported strong financials and the acquisition of a rare disease candidate on the verge...   

China Shows More Of An Open Door To Overseas Medtech Industry

China's influence on global medtech regulation and the country's continuing emergence on the world stage will be felt increasingly in...   

Pharma Q2 Results Preview: Lilly, Biogen, GSK And Gilead

Key strategy updates are coming: GSK will unveil its new R&D approach, Biogen will update investors on its Alzheimer's plans...   

FDA's Alternative 510(k) Proposal Falls Flat With Industry

The US regulatory agency has touted its newly proposed voluntary "expanded abbreviated" 510(k) program as a modern approach to regulation...   

Boston Scientific Gulps Down Claret After Cryterion, In Double-Whammy July

Boston Scientific has inked a deal of up to $270m for embolic protection system developer Claret Medical, marking its second...    

PureTech’s Milk Exosome-Based Technology Draws R&D Pact With Roche

PureTech's milk-derived exosome platform will be used by Roche to generate numerous novel antisense oligonucleotides, potentially earning PureTech more than...   

Mehta Analysis: China, A Populist Pharma Power

With money pouring into biopharma in China, and regulatory reforms favoring market growth and R&D speed, western firms should watch...   

Thursday 19th July 2018

Amazon Hurricane Heading Towards Indian Pharma?

Think Amazon, think disruption, and that’s exactly what could be in store if the online retail juggernaut goes through with...    

Vivli Nonprofit Hopes To Be One-Stop Shop For Clinical Trial Data

GlaxoSmithKline, Pfizer, and Biogen are among those participating in new data-sharing and analytics platform; 2,500 trials currently available to researchers.   

Takeda/Ovid Broaden Pioneering CH24H Inhibitor To Rare Epilepsies

Takeda and partner Ovid are planning new trials in rare pediatric indications for their first-in-class epilepsy drug, including in the...  

Merck's New Pricing Pledge Shows Style Over Substance

A 60% price reduction on hepatitis C drug Zepatier sounds impressive, but the drug has been declining and the HCV...   

Drug Importation Can Be Triggered By 'Excessive' Price Increases; Now US FDA Has To Decide What That Means

Did FDA Commissioner Scott Gottlieb and HHS Secretary Alex Azar have a change of heart on importation? Or are they...   

Who Wants To Be 'Essential'? US FDA Considers Critical Drugs List

To address chronic shortages, FDA may create list of 'essential' drugs, but will suppliers of those products be happy to...   

Expert Warns Of Looming 'Capacity Crunch' For New Cell And Gene Therapy Products

Capacity shortages are looming for manufacturers wanting to develop and commercialize cell and gene therapy products over the next five...   

Allergan's Abicipar Effective With Fewer Injections, But More Inflammation In AMD

Allergan and Molecular Partners said dosing of the VEGF inhibitor every eight or 12 weeks was non-inferior to Lucentis every...   

Exclusivity Period Allowed By OTC Monograph Reform Likely Up To Conference Committee

Next step for OTC monograph reform legislation is Senate consideration; market exclusivity periods are likely focus of House/Senate conference. Separate...   

Adding Multivitamins To SNAP Sprouts Or Wilts In Congress' Decision On Farm Bill

House appoints its farm bill conference committee members primarily from Agriculture Committee but also with reps from committees with oversight for...   

FDA Commissioner’s Rx For US Biosimilars Market: Reform Contracting Practices And Payment Models

In unveiling the agency’s Biosimilar Action Plan, FDA's Gottlieb continued his pattern of provocative remarks by criticizing brand company practices...   

Mersana's ADC Technology Faces A Setback With Partial Clinical Trial Hold

A patient death in a Phase I dose-escalation study of XMT-1522 in patients with HER2-expressing tumors rattled investors, but CEO...   

Health, Beauty And Wellness Launches: BSN, Som Sleep, Monat, Nutrisystem, Celsius, thinkThin

Monat enhances Rejuveniqe; Probiotics, protein in thinkThin oatmeal; Nutrisystem offers Blueprint for genetic action; Celsius powdered sticks in coconut, cranberry-lemon...   

Generics Office At US FDA Could Get New Director Before Uhl Departs

Kathleen Uhl gave seven months' notice of her retirement, which may allow new director to be hired and on-boarded before...    


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks